Biomarkers for synaptic dysfunction in Alzheimer’s disease

Biomarkers for synaptic dysfunction in Alzheimer’s disease

Saved in:

Bibliographic Details
Main Author:	Ruiqing Ni
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2026-02-01
Series:	Neural Regeneration Research
Online Access:	https://journals.lww.com/10.4103/NRR.NRR-D-24-01227
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

The Role of Astrocytes in Synaptic Dysfunction and Memory Deficits in Alzheimer’s Disease
by: Cristina A. Muñoz de León-López, et al.
Published: (2025-06-01)

Glial reactivity correlates with synaptic dysfunction across aging and Alzheimer’s disease
by: Francieli Rohden, et al.
Published: (2025-07-01)

Serum Npas-4 and Nptx-2 Levels in Alzheimer’s Disease: Potential Biomarkers of Synaptic Dysfunction in a Cross-Sectional Study
by: Alev Lazoglu Ozkaya, et al.
Published: (2025-05-01)

Neurogranin in Alzheimer's Disease: Roles in synaptic function, pathology, and potential as a diagnostic biomarker
by: Rajkumar Bavaharini, et al.
Published: (2024-09-01)

Synaptic loss pattern is constrained by brain connectome and modulated by phosphorylated tau in Alzheimer’s disease
by: Ying Luan, et al.
Published: (2025-07-01)

Synaptic biomarkers in CSF aid in diagnosis, correlate with cognition and predict progression in MCI and Alzheimer's disease
by: Douglas Galasko, et al.
Published: (2019-01-01)

KChIP3 fosters neuroinflammation and synaptic dysfunction in the 5XFAD mouse model of Alzheimer’s disease
by: Bolivar Arcos-Encarnación, et al.
Published: (2025-06-01)

Synaptic and synchronic impairments in subcortical brain regions associated with early non-cognitive dysfunction in Alzheimer’s disease
by: Nicolás Riffo-Lepe, et al.
Published: (2026-01-01)

Human brain single-cell data reveal shared synaptic dysfunction and immune abnormality in epilepsy and Alzheimer′s disease
by: YU Xiaolin, ZHANG Erning, SHA Longze
Published: (2025-07-01)

Emerging Link between Alzheimer’s Disease and Homeostatic Synaptic Plasticity
by: Sung-Soo Jang, et al.
Published: (2016-01-01)

Synaptic Dysfunction in Prion Diseases: A Trafficking Problem?
by: Assunta Senatore, et al.
Published: (2013-01-01)

Limbic system synaptic dysfunctions associated with prion disease onset
by: Simote T. Foliaki, et al.
Published: (2024-12-01)

Trans-Synaptic Spread of Amyloid-β in Alzheimer’s Disease: Paths to β-Amyloidosis
by: Annabella Pignataro, et al.
Published: (2017-01-01)

Lactate links exercise to synaptic protection and cognitive enhancement in Alzheimer’s disease models
by: Hao Han, et al.
Published: (2025-06-01)

Pathological Role of Peptidyl-Prolyl Isomerase Pin1 in the Disruption of Synaptic Plasticity in Alzheimer’s Disease
by: Lingyan Xu, et al.
Published: (2017-01-01)

Novel CSF β-synuclein-specific assays signal early synaptic degeneration in Alzheimer’s disease
by: Sherif Bayoumy, et al.
Published: (2025-04-01)

GluA2 palmitoylation by SELENOK modulates AMPAR assembly and synaptic plasticity in Alzheimer's disease
by: Jiaying Peng, et al.
Published: (2025-10-01)

Early synaptic dysfunction of striatal parvalbumin interneurons in a mouse model of Parkinson’s disease
by: Quansheng He, et al.
Published: (2024-11-01)

Cerebrospinal Fluid Biomarkers of Alzheimer Disease
by: Kseniya V. Nevzorova, et al.
Published: (2025-06-01)

Olfactory dysfunction in Alzheimer&rsquo;s disease
by: Zou Y, et al.
Published: (2016-04-01)

Brain-derived neurotrophic factor plays with TRiC: focus on synaptic dysfunction in Huntington’s disease
by: Yingli Gu, et al.
Published: (2025-10-01)

Influence of co-pathology on CSF and plasma synaptic markers SNAP25 and VAMP2 in Alzheimer’s disease and Parkinson’s disease
by: Lorenzo Gaetani, et al.
Published: (2025-05-01)

Inhibition of FAM19A5 reverses synaptic loss and cognitive decline in mouse models of Alzheimer’s disease
by: Han-Byul Kim, et al.
Published: (2025-07-01)

Synaptic markers are associated with cognitive decline after accounting for amyloid burden among an at-risk Alzheimer’s disease cohort
by: Elizabeth M. Planalp, et al.
Published: (2025-06-01)

Plasma membrane remodeling in GM2 gangliosidoses drives synaptic dysfunction.
by: Alex S Nicholson, et al.
Published: (2025-07-01)

SFRP1 upregulation causes hippocampal synaptic dysfunction and memory impairment
by: Guadalupe Pereyra, et al.
Published: (2025-04-01)

The Cardiac Dysfunction Caused by Metabolic Alterations in Alzheimer's Disease
by: Jiayuan Murphy, et al.
Published: (2022-02-01)

Beyond the brain: early autonomic dysfunction in Alzheimer’s disease
by: Carmen Nanclares, et al.
Published: (2025-06-01)

Mitochondrial dysfunction and Alzheimer’s disease: pathogenesis of mitochondrial transfer
by: Yun Wei, et al.
Published: (2024-12-01)

Plasma biomarkers of brain atrophy in Alzheimer's disease.
by: Madhav Thambisetty, et al.
Published: (2011-01-01)

Amyloid blood biomarker detects Alzheimer's disease
by: Andreas Nabers, et al.
Published: (2018-04-01)

Diffusion tensor metrics as biomarkers in Alzheimer's disease.
by: Julio Acosta-Cabronero, et al.
Published: (2012-01-01)

Biomarkers and therapeutic targets in early Alzheimer’s disease: an Olink proteomics study
by: Jianan Wei, et al.
Published: (2025-07-01)

CDK5-mediated hyperphosphorylation of Tau217 impairs neuronal synaptic structure and exacerbates cognitive impairment in Alzheimer’s disease
by: Kangyue Fu, et al.
Published: (2025-08-01)

A systematic review of biomarkers for disease progression in Alzheimer's disease.
by: David J M McGhee, et al.
Published: (2014-01-01)

Dissection of blood–brain barrier dysfunction through CSF PDGFRβ and amyloid, tau, neuroinflammation, and synaptic CSF biomarkers in neurodegenerative disordersResearch in context
by: Agathe Vrillon, et al.
Published: (2025-05-01)

Corrigendum: The cardiac dysfunction caused by metabolic alterations in Alzheimer's disease
by: Jiayuan Murphy, et al.
Published: (2025-08-01)

Bridging systemic metabolic dysfunction and Alzheimer’s disease: the liver interface
by: Dan Song, et al.
Published: (2025-05-01)

Blood‐based biomarkers of Alzheimer's disease: Standardization and comprehensiveness
by: Ying Liu, et al.
Published: (2024-12-01)

Biomarkers in Alzheimer’s disease: Emerging trends and clinical implications
by: Piaopiao Lian, et al.
Published: (2025-05-01)